Alerts will be sent to your verified email
Verify EmailBACPHAR
Bacil Pharma balance sheet is weak and might have solvency issues
Yes, The debt of Bacil Pharma is increasing.
Latest debt of Bacil Pharma is ₹0.05 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹0.05 Crs.
Yes, profit is increasing.
The profit of Bacil Pharma is -₹0.06 Crs for Mar 2024, -₹0.1 Crs for Mar 2023 and -₹3.86 Crs for Mar 2022
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bacil Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
Companies resources are majorly tied in miscellaneous assets